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Background
Total antinuclear antibodies (ANA) are widely detected
in pediatric rheumatology, while the data about specific
ANA are few and controversial.
Aim
To evaluate the levels of ds-DNA, Sm, anti-Ro, anti-Jo1,
Scl-70 antibodies in serum of children with connective
tissue diseases (CTDs). To look for correlations between
clinical features of the CTDs, age and gender of children
and specific ANA concentrations.
Methods
We observed 187 children from 2 to 18 years (median
13 years, 25‰–9 years, 75‰–15 years); 70 (37,4%)
boys, 117 (62,6%) – girls with systemic lupus erythema-
tosis (SLE), juvenile rheumatoid arthritis (JRA), spondy-
loarthritis (SA), scleroderma (systemic/localized),
dermatomyosites and mixed CTD (MCTD). All patients
undergo common rheumatologic examination. Specific
ANA were measured with Elia method on ImmunoCAP
250 (Phadia).
Results
Only girls with CTDs had positive specific ANA. There
were no significant differences between the ages of chil-
dren with positive and negative results and with differ-
ent positive antibodies. Duration of the disease and
concentration of antibodies didn’t correlate. Children
with positive results had severer forms of CTDs, but
there were also 4 patients with active SLE and negative
results of measured antibodies. Anti-Ro were detected
in the «above» concentrations in 7 cases (all with SLE)
and anti-Jo-1 - in all positive cases. 7 children with SLE
had combination of positive ds-DNA and Sm or ds-
DNA and anti-Ro. (Table 1)
Conclusion
Ds-DNA, Sm, anti-Ro, anti-Jo1 were found predomi-
nantly in girls with SLE. The levels of antibodies didn’t
correlate with age and duration of the disease. Evalua-
tion of Scl-70 was not indicative for systemic or loca-
lized scleroderma. Further observations are necessary to
evaluate the prognostic value of measured specific ANA
in these children.
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Table 1
ANA Number of positive results Negative results (median concentration; 25‰;7 5 ‰)
dsDNA 19 (10,1%) (17 SLE, 1 JRA, 1 scleroderma) 1 (0,4;2) (IU/ml)
Sm 4 (2%) (4 SLE) 0,1 (0;0,3) (U/ml)
anti-Ro 13 (7%) (10 SLE, 2 MCTD, 1 systemic scleroderma) 0,1 (0;0,3) (U/ml)
anti-Jo1 2 (1%) (2 MCTD) 0 (0; 0,1) (U/ml)
Scl-70 0 0 (0;0,1) (U/ml)
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